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1 | INTRODUCTION
The ﬁeld of radiotherapy (RT) has beneﬁted substantially from
advancements in Image-Guided Radiotherapy (IGRT) in the past 15
years. IGRT now constitutes the integration of a wide range of imag-
ing technology with modern RT delivery systems that include 3D
anatomical and functional-based imaging for tumor volume identiﬁ-
cation, 3D target volume localization, and motion management infor-
mation for precise patient setup and monitoring.1,2 To streamline
this complex process, system integration of planning and delivery
with multimodality IGRT technologies is now a primary selling point
for vendors. This integration becomes more complex with the
increased number of image-guided patient positioning and motion
management options. Current IGRT technologies include not only
various x-ray based imaging systems but also other modalities, such
as video/infrared (IR) cameras, ultrasound (US), and electromagnetic
ﬁeld systems. The capital purchase decision makers at hospitals wel-
come tools that allow for improved image guidance when it is con-
sistent with their strategies for return on investment. But this may
raise multiple issues that need to be addressed by medical physicists,
including safe and practical implementation and commissioning, per-
sonnel qualiﬁcation and training of staff, updates and servicing to
ensure integration between systems, and of course reimbursement
constraints. This brings us to our debate topic: Will more IGRT sys-
tems implemented in the clinic lead to better outcomes for RT treat-
ments?
Arguing for the proposition is Dr. Baozhou Sun. Dr. Sun is an
assistant professor and chief of quality assurance services of radia-
tion oncology at Washington University in St. Louis. He earned his
Ph.D. in applied science from the College of William and Mary in
2005. Dr. Sun ﬁnished his medical physics residency training at
Washington University in St. Louis in 2012 and became a faculty
member at the same institution. He is certiﬁed in Therapeutic
Radiological Physics by the American Board of Radiology. His
research interests include quality assurance, proton therapy, imaging-
guided radiation therapy, and medical informatics.
Arguing against the proposition is Dr. Jenghwa Chang. Dr.
Jenghwa Chang received his Ph.D. in electrical engineering from
Polytechnic University and is an ABR-certiﬁed medical physicist. He
is currently an Associate Professor at Radiation Medicine of North-
well Health supervising the training/education of medical/physics
residents and overseeing the quality assurance program for physics.
Previously Dr. Chang held positions with Weill Cornell Medical Col-
lege, NYU Langone Medical Center, and Memorial Sloan-Kettering
Cancer Center. He is also a physicist surveyor for ACR Radiation
Oncology Practice Accreditation (ROPA) program. His research inter-
est includes optical diffusion tomography, Electronic Portal Imaging
Device (EPID) dosimetry, MV/kV cone beam CT (CBCT), magnetic
resonance imaging (MRI)-guided treatment planning, panoramic
CBCT, and setup uncertainty of single isocenter for multiple targets
technique.
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The goal of RT is to deliver high dose to the tumor while spar-
ing adjacent normal healthy tissues. The geometric accuracy of
dose deposited to the desired target is critical to ensure high
quality of treatments. IGRT has been introduced to reduce geo-
metric uncertainties in RT. The diverse technologies of IGRT
have been proved to be an effective quality control process that
reduces the systematic and random uncertainties in the treat-
ment process.3 In the era of precision and personalized medi-
cine, more IGRT technologies should be developed and
implemented to provide more beneﬁts to patient care. The
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overall beneﬁts of these IGRT technologies can be summarized
in the following aspects:
1. Treatment margin reduction. During the planning process, in
order to ensure adequate coverage of the clinical target volume,
a margin has to be added to compensate the daily positioning
uncertainties and internal organ motion. With the introduction of
IGRT, the margins can be signiﬁcantly reduced, leading to a sub-
stantial reduction in the normal tissue irradiation.
2. Hypofractionated RT targeting accuracy. Advances in IGRT has
enabled hypofractionated RT and stereotactic RT (SBRT or SRS),
which reduces the cost from conventionally fractionated RT and
has clinically demonstrated superior beneﬁts to conventional
treatments in speciﬁc disease sites, such as lung, brain, liver, and
prostate.
3. Anatomy change monitoring and adaptive RT. With IGRT, the
daily or real-time imaging data can be used to monitor changes
in tumor size and shape over a course of treatment and make
ofﬂine or online adaptations to the treatment plan. Both complex
geometric errors and patient-speciﬁc variation (e.g., tumor shrink-
age) can be corrected through adaptive planning.
Overall, the use of IGRT in improving treatment margin reduc-
tion, hypofractionated RT accuracy, and adaptive RT will ultimately
improve clinical outcomes.4,5
It is without questions that IGRT is critical for ensuring treat-
ment quality of RT. Currently, there exist a variety of commercial
IGRT technologies readily available for clinical use. Different IGRT
systems are used for different clinical scenarios depending on the
treatment sites, expected magnitude of errors, and purpose of the
application (positioning, target localization, or real-time tumor track-
ing). The IGRT systems can be generally divided into radiation-based
and nonradiation-based systems. Each system has its unique
advantages and limitations when implemented in the clinic. The radi-
ation-based systems mainly use kV or MV imaging techniques and
include:
1. 2D planar imaging using MV EPID and kV on-board imager (OBI).
Both EPID and kV OBI imaging systems are standard IGRT equip-
ment for almost all linacs. These images are lack of soft tissue
contrast, but provide bony landmarks as an aligning surrogate.
The 2D kV with ﬁducials can also be used for tumor tracking for
robotic radiosurgery system.
2. 3D volumetric imaging technology (CBCT, MV helical CT, and in-
room helical CT). CBCT provides better contrast resolution than
MV helical CT (e.g., tomotherapy) and is the most commonly
used system for daily localization on modern linacs. Image quality
of MV CT is inferior compared to kV CT, but MV CT can reduce
metal artifacts, which is useful for patients with dental ﬁlling or
prosthesis. In-room CT or CT-on-rails has been developed for
IGRT. However, it has not been adopted by many due to its
bulky size, high cost, and impracticality to implement in a regular
linac room. Recently, a more compact design of mobile CTs has
emerged and implemented for proton therapy.6 CT-on-rails or
mobile CTs can also be used with brachytherapy high-dose rate
(HDR) after-loaders for image guidance brachytherapy.7
Nevertheless, the 3D volumetric imaging does not provide “snap
shot” information and cannot be used for intra-fraction monitoring
or correction. With the advantages of no extra radiation to patients,
the nonradiation-based systems have also been widely implemented
in RT, which include:
1. Camera-based systems (e.g., surface monitor systems such as
VisionRT or C-Rad). These systems can be used for patient posi-
tioning and intra-fraction monitoring. Yet they are mostly limited
to situations where external surface acts as a reliable surrogate
for internal position or motion.
2. Electromagnetic tracking (e.g., Calypso). This system uses electro-
magnetic transponders embedded within the tumor, and motion
of these transponders may be tracked in real time using a detec-
tor array system. However, it is only limited to prostate.
3. US-based system (e.g., BAT, Clarity). US has several advantages
including relatively low cost, avoidance of invasive seed
placement procedures, and the potential of reduced patient
setup times. Sites of common application include prostate and
breast.
During the last decade, the development of image guidance in
the context of radiation therapy has been substantially accelerated.
The recent development in MR-guided radiation therapy has signiﬁ-
cantly advanced the ﬁeld of IGRT. MR-guided treatment machines
have better contrast for soft tissue and provide real-time assessment
of internal soft-tissue anatomy and motion and allow for intra-frac-
tional corrections.
There is no single system that can be applied for all clinical
scenarios as a treatment machine is often used to treat multiple
sites. Different treatment sites and modalities require different
levels of accuracy. For example, a simple 2D or 3D treatments,
MV portal imaging is sufﬁcient for localization, giving the
required level of setup accuracy is on the order of cm. While for
targets adjacent to critical structures, daily kV or CBCT might be
required to reduce setup uncertainties to the order of mm. For
hypofractionated treatment (SBRT or SRS), real-time tracking is
considered ideal to monitor the intra-fractional motion. Therefore,
more IGRT technologies implemented in the clinic should bring
more beneﬁts for high-quality treatments. For a large-size RT
clinic, there are usually dedicated machines with multiple IGRT
systems for SBRT/SRS treatments. And integration of multiple
IGRT systems into one single room is available to provide more
ﬂexibility and better performance. There are several studies on
integration of 3D US to CBCT for prostate treatments.8,9 For
example, some newly released linac products are equipped with
MV, kV 2D/2D, CBCT, respiratory gating, and optical surface
monitoring systems. There is no doubt that more IGRT technolo-
gies implemented will lead to better geometric precision for
treatments, which will provide more beneﬁts to patients and
improve the quality of patient care.
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Ever since the in-room kV imaging system became commercially
available at the beginning of this millennium, there has been an
explosion of new IGRT systems introduced into the treatment room.
These systems adopt complex combinations of imaging sources,
detectors, and processing algorithms. Recently, one of vendors’
favorite marketing points for radiotherapy treatment machines is the
“IGRT integration” with all possible imaging modalities on board,
such as kV/MV 2D projection imaging, kV/MV 3D volumetric imag-
ing, surface-based imaging, electromagnetic imaging, ultrasound.
Moreover, MRI-based IGRT systems combined with the Cobalt or
linac treatment unit are on the horizon and promised to elevate the
IGRT complexity to a whole new level. This IGRT technology push is
based on the seemingly indisputable claim “more IGRT systems
implemented in clinic are better for radiotherapy outcomes.” That is,
more IGRT systems offer more treatment options so that the best
technology or combination of technologies can be used to guide the
treatment. This would allow us to see more details of patient anat-
omy, physiology, and pathology, which can lead to better tumor tar-
geting and less normal tissue complications.
However, this improvement is usually achieved at the cost of
increased complexity of the IGRT program. Speciﬁcally, therapists,
radiation oncologists, and medical physicists might need to spend
longer time to perform imaging scans, identify the treatment target,
and correct patient’s positioning. In addition, the longer we spend on
IGRT processing and analysis, the more likely the patient’s position
has already changed since ﬁrst imaged and might require a repeat of
imaging, which further prolongs the IGRT procedure. The additional
machine time and personnel time spent on these multilevel imaging
studies need to be either paid by insurance companies or absorbed
by hospitals. Finally, the people present at an IGRT procedure must
be fully competent in the technology (or technologies) chosen for
that procedure. In theory, these additional personnel, ﬁnancial, and
educational/training resources must be available when more IGRT
systems are incorporated. However, as Yogi Berra pointed out, “In
theory there is no difference between theory and practice. In prac-
tice there is.” What is the IGRT in practice?
First, insurance companies are limiting medical payments. The
United States has the highest healthcare expenditure per capita in
the world,10 and the trend of increase is not sustainable.11 In order
to control the medical spending, insurance companies are cutting
back the reimbursement rate, particularly for procedures employing
advanced medical technologies. In the radiotherapy billing code sys-
tem, bundled payments have been introduced in the past few years,
so the payment for an IGRT treatment is ﬁxed regardless of the
complexity of the procedure. Therefore, the extra cost for IGRT, if
there is any, needs to be absorbed by the hospitals.
Second, the machine and personnel times spent performing IGRT
are often restricted. Currently, most clinics schedule a 15- or 30-
minute slot, respectively, for the regular fractionated or SRS/SBRT
cases. These time slots are not always enough to perform all desired
imaging studies for guiding the treatment, particularly for the
patients who need longer time for image co-registration of complex
anatomy, or require frequent imaging to correct for signiﬁcant intra-
fraction motion. Hospitals used to absorb the extra cost for proce-
dures requiring longer treatment time but without getting additional
reimbursement. However, in order to survive today’s competitive
healthcare environment, a radiotherapy clinic needs to maintain a
sustainable patient throughput and schedule patients within the
allowed time slot. As a result, most hospitals are reluctant to carry
this ﬁnancial burden.
Furthermore, personnel qualiﬁcation for IGRT procedures is
questionable. As identiﬁed by professional societies12 and accredita-
tion bodies,13 one key factor to the success of an IGRT program is
making sure the personnel has sufﬁcient education/training with the
IGRT systems and procedures. Ideally, education/training policy
should be strictly enforced so that the IGRT is always operated and
supervised by qualiﬁed therapists, medical physicists, and radiation
oncologists. In reality, with more (including IGRT) technologies intro-
duced into the ﬁeld,14 it has become increasingly more difﬁcult to
maintain adequate education/training for the staff. Moreover, it is
more challenging to interpret the results from a combination of vari-
ous IGRT modalities (e.g., optical surface imaging combined with
CBCT, or electromagnetic imaging combined CBCT) than from indi-
vidual modality. However, most IGRT education/training focuses on
the learning of individual system while the processing of mutual
information between modalities is usually under-addressed. Without
extra training and knowledge, the staff might not feel comfortable
making a clinical decision, particularly when the results from multiple
imaging studies do not agree.
Finally, more IGRT systems also challenge the logistics of radio-
therapy delivery. A radiotherapy room clogged with multiple IGRT
systems is not only difﬁcult for therapists to operate but also more
likely to have treatment-related incidents, e.g., collision, particularly
for vaults built before the IGRT era. Moreover, therapists can be
easily distracted by all the imaging equipment in the room and extra
monitors on the treatment counsel. More IGRT systems also lead to
longer time for morning QA, more scheduling conﬂicts for machine
QA and maintenance, and extra competition for storage spaces. In
addition, frequent personnel turnover and scheduling conﬂict might
force the institution to staff a machine with inexperienced people.
This situation is made worse by the increased use of per-diem thera-
pists and medical physicists (for cost-cutting purpose) who usually
have limited knowledge and experience on the IGRT program the
institution has implemented. With all the risks added together, the
safety of the radiation delivery might be compromised and the bene-
ﬁt of more IGRT technology is offset by possible increased errors.
In conclusion, complexity is the ultimate enemy. The statement
“more IGRT systems implemented in clinic are better for radiother-
apy outcomes” is only true in theory but could not materialize in
practice because most clinics do not have enough machine time and
man power to deal with the added complexity. Even worse, imple-
menting more complex IGRT procedures without sufﬁcient resources
might actually lead to more mistakes and eventually degrade the
quality of radiotherapy program.
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I do not agree with the statement “The additional machine time and
personnel time spent on these multilevel imaging studies need to be
either paid by insurance companies or absorbed by hospitals.” The
availability of multiple imaging technologies does not always increase
the additional personnel and machine time, but will increase the ﬂex-
ibility of IGRT for different sites. Users do not need to take multiple
imaging scans for each patient, but instead, select the best IGRT
technique based on treatment sites or requirement of accuracy. Fur-
thermore, as I described in the opening statement, with advanced
IGRT technologies for tumor localization and real-time tracking,
SBRT has been widely accepted and implemented. With multiple
advanced IGRT techniques implemented, more and more patients
may be eligible for SBRT treatments. SBRT treatments, facilitated by
IGRT, can reduce the treatment fractions from 35 to 3–5 fractions
or even to a single fraction, which signiﬁcantly reduces the machine
time, personnel time, and overall cost.
With regard to the personnel qualiﬁcation for IGRT procedures,
I agree that personnel should have adequate training before a new
IGRT technology is implemented. However, that does not draw the
conclusion that we do not need to implement more IGRT technolo-
gies. IMRT or VMAT techniques are much more complex than 3D
Conformal RT. It is incorrect that we discourage the implementation
of IMRT or VMAT in the clinic due to its complexity or ignore the
facts that IMRT or VMAT can provide better clinical outcomes than
conventional 2D or 3D treatments. In the same way, multiple IGRT
technologies result in more complicated RT treatments with better
quality. Lack of training is the ultimate enemy, complexity is not.
Complexity of multiple IGRT technologies can be managed by appro-
priate training, in order to ensure that the beneﬁts of diverse IGRT
are maximized to provide the best quality of patient care.
The “opposed” statement suggests that more IGRT technologies
challenge the logistics of RT delivery due to clogged space, more
time for morning QA, and therapist’s distraction because of more
IGRT equipment. However, we should note that advanced treatment
machines provide integrated IGRT technologies. The radiographic,
ﬂuoroscopic, kV CBCT, and MV CBCT are seamless integrated in
modern linacs. Those optical camera systems, i.e., VisionRT, are ceil-
ing mounted and take little space. The workﬂow are efﬁciently
designed and integrated in many advanced RT systems. Comprehen-
sive and automated QA tools are available for imaging QA and can
prevent errors due to multiple imaging technologies.
3.B | Dr. Jenghwa Chang
In theory, I would agree with Dr. Sun’s opening statement, particu-
larly, “Overall, the use of IGRT . . . will ultimately improve clinical
outcomes.” But this statement might not hold in clinical practice.
I have gone over in my opening statement the reality of the health-
care industry and the obstacles a clinic might face when trying to
implement multiple IGRT systems beyond necessity or its capacity.
In this rebuttal, I would like to focus on a few points brought up by
Dr. Sun.
First, in the era of value-based medicine, in addition to the goal
of achieving “better clinical outcomes,” another aspect should also
be considered: are these aggressive and expensive treatments with
high demands in IGRT technologies really necessary? Are there less-
expensive alternatives that can attain equivalent or better clinical
outcomes? These questions are generally not answered and a couple
of clinical trials are looking into them. For example, RTOG 0631
compares the treatment outcomes of 16 Gy or 18 Gy single-fraction
SRS of spine metastasis under high-precision (better than 2 mm)
image guidance with 8 Gy single-fraction 2D or 3D external beam
treatment with generous (1–2 cm) PTV margin.15
Moreover, successful implementation of multiple IGRT systems in
a few large academic centers may not be directly translated to stand-
alone clinics or community hospitals that constitute the majority of
oncology practices in the United States.16 This is mostly due to the
differences in available resources and billing code systems. Large aca-
demic centers usually provide more research time and funding sup-
port to physician and physics faculties for investigating and
experimenting new IGRT technologies. Stand-alone clinics or commu-
nity hospitals, however, have very limited ﬁnancial, personnel, and
training resources for managing even the basic clinical IGRT systems.
Finally, technology is the most signiﬁcant contributing factor to
the growth in healthcare spending, and it is essential to attain good
value for money spent in technology development.17 The “substan-
tially accelerated” pace in developing more complex IGRT technolo-
gies needs to take a breath. Instead, more efforts should be spent
on developing IGRT systems that are simpler, more robust, and less
expensive but can still provide good values. Until then, the state-
ment “more IGRT systems implemented in clinic are better for radio-
therapy outcomes” is only true in theory but not in practice.
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